Drugs / Follicle Stimulating Hormone

Trials 4

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial · 1 missed
Phase 0 NCT03356964 Nov 2017 → Feb 2020 progesterone resistance ART Fertility Clinics LLC Completed Missed primary
Phase 11 trial
Phase 1 NCT06414096 Oct 2024 → Nov 2025 overdue female infertility, obesity disorder University of Colorado, Denver Recruiting No outcome recorded
Phase 21 trial
Phase 2 NCT00064987 Apr 2001 → Oct 2012 Kallmann syndrome Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Terminated No outcome recorded Stop: Enrollment
Phase 41 trial
Phase 4 NCT04430621 Jul → Aug 2020 — Federico II University Unknown No outcome recorded
Comparator or background therapy4 trials
Phase 1/2 NCT02179255 Background Aug 2014 → Jun 2021 female infertility Center for Human Reproduction Unknown No outcome recorded
Phase 3 NCT07346235 Comparator Mar 2026 → Jan 2028 expected female infertility American Hospital 2 Kosovo Not yet recruiting No outcome recorded
Phase 3 NCT01044862 Comparator Jun 2010 → Oct 2013 infertility disorder, pregnancy disorder Yale University Completed No outcome recorded
Phase 4 NCT01403532 Comparator Sep 2009 → Dec 2012 Kallmann syndrome Shanghai Jiao Tong University School of Medicine Completed Met primary

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as follicle stimulating hormone “Follicle stimulating hormone(FSH),75U, im, 3 times/week, one year;” NCT01403532 ↗
7

NCT00064987 ↗

NCT07346235 ↗

NCT02179255 ↗

NCT06414096 ↗

NCT03356964 ↗

NCT01044862 ↗

NCT04430621 ↗

Known as FSH “Follicle stimulating hormone(FSH),75U, im, 3 times/week, one year;” NCT01403532 ↗
3

“Follicle Stimulating Hormone (FSH)” NCT01044862 ↗

“Follicle-stimulating hormone (FSH)” NCT07346235 ↗

“follicle stimulating hormone (FSH)” NCT00064987 ↗

Modality Protein / enzyme biologic “recombinant follicle-stimulating hormone pretreatment” PMID 24037890 ↗ Sep 2013
Route Subcutaneous “75 IU subcutaneous injection daily for four months.” NCT00064987 ↗